|
1
|
Hamilton DW: Functional role of periostin
in development and wound repair: Implications for connective tissue
disease. J Cell Commun Signal. 2:9–17. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Norris RA, Damon B, Mironov V, Kasyanov V,
Ramamurthi A, Moreno-Rodriguez R, Trusk T, Potts JD, Goodwin RL,
Davis J, et al: Periostin regulates collagen fibrillogenesis and
the biomechanical properties of connective tissues. J Cell Biochem.
101:695–711. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lindsley A, Snider P, Zhou H, Rogers R,
Wang J, Olaopa M, Kruzynska-Frejtag A, Koushik SV, Lilly B, Burch
JB, et al: Identification and characterization of a novel Schwann
and outflow tract endocardial cushion lineage-restricted periostin
enhancer. Dev Biol. 307:340–355. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Horiuchi K, Amizuka N, Takeshita S,
Takamatsu H, Katsuura M, Ozawa H, Toyama Y, Bonewald LF and Kudo A:
Identification and characterization of a novel protein, periostin,
with restricted expression to periosteum and periodontal ligament
and increased expression by transforming growth factor beta. J Bone
Miner Res. 14:1239–1249. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Conway SJ and Molkentin JD: Periostin as a
heterofunctional regulator of cardiac development and disease. Curr
Genomics. 9:548–555. 2008. View Article : Google Scholar
|
|
6
|
Ruan K, Bao S and Ouyang G: The
multifaceted role of periostin in tumorigenesis. Cell Mol Life Sci.
66:2219–2230. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Morra L and Moch H: Periostin expression
and epithelial-mesenchymal transition in cancer: A review and an
update. Virchows Arch. 459:465–475. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ratajczak-Wielgomas K and Dziegiel P: The
role of periostin in neoplastic processes. Folia Histochem
Cytobiol. 53:120–132. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kudo Y, Siriwardena BS, Hatano H, Ogawa I
and Takata T: Periostin: Novel diagnostic and therapeutic target
for cancer. Histol Histopathol. 22:1167–1174. 2007.PubMed/NCBI
|
|
10
|
Nuzzo PV, Buzzatti G, Ricci F, Rubagotti
A, Argellati F, Zinoli L and Boccardo F: Periostin: A novel
prognostic and therapeutic target for genitourinary cancer? Clin
Genitourin Cancer. 12:301–311. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Siriwardena BS, Kudo Y, Ogawa I, Kitagawa
M, Kitajima S, Hatano H, Tilakaratne WM, Miyauchi M and Takata T:
Periostin is frequently overexpressed and enhances invasion and
angiogenesis in oral cancer. Br J Cancer. 95:1396–1403. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang Y, Zhang G, Li J, Tao Q and Tang W:
The expression analysis of periostin in human breast cancer. J Surg
Res. 160:102–106. 2010. View Article : Google Scholar
|
|
13
|
Bao S, Ouyang G, Bai X, Huang Z, Ma C, Liu
M, Shao R, Anderson RM, Rich JN and Wang XF: Periostin potently
promotes metastatic growth of colon cancer by augmenting cell
survival via the Akt/PKB pathway. Cancer Cell. 5:329–339. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhu M, Fejzo MS, Anderson L, Dering J,
Ginther C, Ramos L, Gasson JC, Karlan BY and Slamon DJ: Periostin
promotes ovarian cancer angiogenesis and metastasis. Gynecol Oncol.
119:337–344. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Baril P, Gangeswaran R, Mahon PC, Caulee
K, Kocher HM, Harada T, Zhu M, Kalthoff H, Crnogorac-Jurcevic T and
Lemoine NR: Periostin promotes invasiveness and resistance of
pancreatic cancer cells to hypoxia-induced cell death: Role of the
beta4 integrin and the PI3k pathway. Oncogene. 26:2082–2094. 2007.
View Article : Google Scholar
|
|
16
|
Malanchi I, Santamaria-Martínez A, Susanto
E, Peng H, Lehr HA, Delaloye JF and Huelsken J: Interactions
between cancer stem cells and their niche govern metastatic
colonization. Nature. 481:85–89. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lee YJ, Kim IS, Park SA, Kim Y, Lee JE,
Noh DY, Kim KT, Ryu SH and Suh PG: Periostin-binding DNA aptamer
inhibits breast cancer growth and metastasis. Mol Ther.
21:1004–1013. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Puglisi F, Puppin C, Pegolo E, Andreetta
C, Pascoletti G, D'Aurizio F, Pandolfi M, Fasola G, Piga A, Damante
G, et al: Expression of periostin in human breast cancer. J Clin
Pathol. 61:494–498. 2008. View Article : Google Scholar
|
|
19
|
Xu D, Xu H, Ren Y, Liu C, Wang X, Zhang H
and Lu P: Cancer stem cell-related gene periostin: A novel
prognostic marker for breast cancer. PLoS One. 7:e466702012.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Nuzzo PV, Rubagotti A, Zinoli L, Salvi S,
Boccardo S and Boccardo F: The prognostic value of stromal and
epithelial periostin expression in human breast cancer: Correlation
with clinical pathological features and mortality outcome. BMC
Cancer. 16:952016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tian B, Zhang Y and Zhang J: Periostin is
a new potential prognostic biomarker for glioma. Tumour Biol.
35:5877–5883. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Tian Y, Choi CH, Li QK, Rahmatpanah FB,
Chen X, Kim SR, Veltri R, Chia D, Zhang Z, Mercola D, et al:
Correction: Overexpression of periostin in stroma positively
associated with aggressive prostate cancer. PLoS One.
10:e01303332015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Li JS, Sun GW, Wei XY and Tang WH:
Expression of periostin and its clinicopathological relevance in
gastric cancer. World J Gastroenterol. 13:5261–5266. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Tai IT, Dai M and Chen LB: Periostin
induction in tumor cell line explants and inhibition of in vitro
cell growth by anti-periostin antibodies. Carcinogenesis.
26:908–915. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Gillan L, Matei D, Fishman DA, Gerbin CS,
Karlan BY and Chang DD: Periostin secreted by epithelial ovarian
carcinoma is a ligand for alpha(V)beta(3) and alpha(V)beta(5)
integrins and promotes cell motility. Cancer Res. 62:5358–5364.
2002.PubMed/NCBI
|
|
26
|
Liu Y and Liu BA: Enhanced proliferation,
invasion, and epithelial-mesenchymal transition of
nicotine-promoted gastric cancer by periostin. World J
Gastroenterol. 17:2674–2680. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ratajczak-Wielgomas K, Grzegrzolka J,
Piotrowska A, Gomulkiewicz A, Witkiewicz W and Dziegiel P:
Periostin expression in cancer-associated fibroblasts of invasive
ductal breast carcinoma. Oncol Rep. 36:2745–2754. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lakhani SR, Ellis IO, Schnitt SJ, Tan PH
and van de Vijver MJ: WHO Classification of Tumours of the Breast.
4th edition. IARC Press; Lyon: 2012
|
|
29
|
Schmittgen TD and Livak KJ: Analyzing
real-time PCR data by the comparative C(T) method. Nat Protoc.
3:1101–1108. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Remmele W and Stegner HE: Recommendation
for uniform definition of an immunoreactive score (IRS) for
immunohistochemical estrogen receptor detection (ER-ICA) in breast
cancer tissue. Pathologe. 8:138–140. 1987.In German. PubMed/NCBI
|
|
31
|
Mueller-Holzner E, Fink V, Frede T and
Marth C: Immunohistochemical determination of HER2 expression in
breast cancer from core biopsy specimens: A reliable predictor of
HER2 status of the whole tumor. Breast Cancer Res Treat. 69:13–19.
2001. View Article : Google Scholar
|
|
32
|
Nuzzo PV, Rubagotti A, Argellati F, Di
Meglio A, Zanardi E, Zinoli L, Comite P, Mussap M and Boccardo F:
Prognostic value of preoperative serum levels of periostin (PN) in
early breast cancer (BCa). Int J Mol Sci. 16:17181–17192. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Erkan M, Kleeff J, Gorbachevski A, Reiser
C, Mitkus T, Esposito I, Giese T, Büchler MW, Giese NA and Friess
H: Periostin creates a tumor-supportive microenvironment in the
pancreas by sustaining fibrogenic stellate cell activity.
Gastroenterology. 132:1447–1464. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wang Z and Ouyang G: Periostin: A bridge
between cancer stem cells and their metastatic niche. Cell Stem
Cell. 10:111–112. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Shao R, Bao S, Bai X, Blanchette C,
Anderson RM, Dang T, Gishizky ML, Marks JR and Wang XF: Acquired
expression of periostin by human breast cancers promotes tumor
angiogenesis through up-regulation of vascular endothelial growth
factor receptor 2 expression. Mol Cell Biol. 24:3992–4003. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Contié S, Voorzanger-Rousselot N, Litvin
J, Clézardin P and Garnero P: Increased expression and serum levels
of the stromal cell-secreted protein periostin in breast cancer
bone metastases. Int J Cancer. 128:352–360. 2011. View Article : Google Scholar
|
|
37
|
Vardaki I, Ceder S, Rutishauser D,
Baltatzis G, Foukakis T and Panaretakis T: Periostin is identified
as a putative metastatic marker in breast cancer-derived exosomes.
Oncotarget. 7:74966–74978. 2016.PubMed/NCBI
|
|
38
|
Lv H, Liu R, Fu J, Yang Q, Shi J, Chen P,
Ji M, Shi B and Hou P: Epithelial cell-derived periostin functions
as a tumor suppressor in gastric cancer through stabilizing p53 and
E-cadherin proteins via the Rb/E2F1/p14ARF/Mdm2 signaling pathway.
Cell Cycle. 13:2962–2974. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Kim CJ, Sakamoto K, Tambe Y and Inoue H:
Opposite regulation of epithelial-to-mesenchymal transition and
cell invasiveness by periostin between prostate and bladder cancer
cells. Int J Oncol. 38:1759–1766. 2011.PubMed/NCBI
|
|
40
|
Yoshioka N, Fuji S, Shimakage M, Kodama K,
Hakura A, Yutsudo M, Inoue H and Nojima H: Suppression of
anchorage-independent growth of human cancer cell lines by the
TRIF52/periostin/OSF-2 gene. Exp Cell Res. 279:91–99. 2002.
View Article : Google Scholar : PubMed/NCBI
|
